2-methyl-thieno-benzodiazepine lyophilized formulation

Details 2-methyl-thieno-benzodiazepine lyophilized formulation 2-methyl-thieno-benzodiazepine lyophilized formulation

A - Human Necessities

61

K

A61K 31/5513 (2006.01) A61K 9/19 (2006.01) A61K 31/7012 (2006.01) A61K 47/12 (2006.01) A61K 47/26 (2006.01) A61P 25/18 (2006.01) A61P 25/28 (2006.01)

Patent

CA 2448724

The invention provides an amorphous, lyophilized, parenteral formulation of olanzapine.

L'invention concerne une formulation amorphe lyophilisée parentérale d'olanzapine.

Affiliated with

Also associated with

Rating

2-methyl-thieno-benzodiazepine lyophilized formulation does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 2-methyl-thieno-benzodiazepine lyophilized formulation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2-methyl-thieno-benzodiazepine lyophilized formulation will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1893905